Close Menu

Gastrointestinal

News on in vitro diagnostics for gastrointestinal disease.

The analyzer and assay use immunofluorescent technology to detect H. pylori antigens in human stool and helps eliminate subjectivity.

The four kits are compatible with the i-Track automated analyzer for biotherapy monitoring, which received CE marking in late 2019.

The company's Curian immunoassay instrument is currently in front of the FDA, and the PediaStat will likely be submitted later this year.

The agreement will bring Exalenz's BreathID Breath Test Systems, a urea breath test platform for H. pylori detection, into Meridian's portfolio.

The companies will use ProSciento's Nash Pass patient registry and Nordic Bioscience's biomarker technology to validate the translational biomarkers.